BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,096 filers reported holding BAXTER INTL INC in Q4 2020. The put-call ratio across all filers is 0.87 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,079,336 | -12.9% | 33,282 | +22.3% | 0.02% | -4.0% |
| Q2 2023 | $1,239,869 | +7.9% | 27,214 | -3.9% | 0.02% | +4.2% |
| Q1 2023 | $1,148,983 | -48.7% | 28,328 | -35.5% | 0.02% | -41.5% |
| Q4 2022 | $2,239,569 | -22.8% | 43,939 | -18.4% | 0.04% | -30.5% |
| Q3 2022 | $2,902,000 | -10.7% | 53,877 | +6.4% | 0.06% | -4.8% |
| Q2 2022 | $3,251,000 | -7.9% | 50,615 | +11.2% | 0.06% | +6.9% |
| Q1 2022 | $3,529,000 | -15.6% | 45,511 | -6.6% | 0.06% | -10.8% |
| Q4 2021 | $4,183,000 | +2.3% | 48,724 | -4.2% | 0.06% | -7.1% |
| Q3 2021 | $4,090,000 | -33.0% | 50,853 | -29.7% | 0.07% | -36.9% |
| Q1 2021 | $6,105,000 | -0.2% | 72,378 | -5.1% | 0.11% | -5.1% |
| Q4 2020 | $6,120,000 | -4.4% | 76,273 | -4.2% | 0.12% | -17.0% |
| Q3 2020 | $6,405,000 | -7.5% | 79,653 | -0.9% | 0.14% | -13.5% |
| Q2 2020 | $6,922,000 | -23.0% | 80,399 | -27.4% | 0.16% | -37.1% |
| Q1 2020 | $8,987,000 | +9.4% | 110,695 | +12.7% | 0.26% | +39.2% |
| Q4 2019 | $8,215,000 | +2.8% | 98,241 | +7.5% | 0.19% | -3.1% |
| Q3 2019 | $7,992,000 | -7.4% | 91,369 | -13.3% | 0.19% | -7.2% |
| Q2 2019 | $8,628,000 | -19.6% | 105,344 | -20.2% | 0.21% | -19.5% |
| Q1 2019 | $10,727,000 | +33.3% | 131,935 | +7.9% | 0.26% | +11.7% |
| Q4 2018 | $8,046,000 | -8.5% | 122,249 | +7.1% | 0.23% | +4.1% |
| Q3 2018 | $8,795,000 | +3.4% | 114,093 | -0.9% | 0.22% | -3.5% |
| Q2 2018 | $8,503,000 | +14.8% | 115,154 | +1.1% | 0.23% | +9.0% |
| Q1 2018 | $7,408,000 | -0.3% | 113,897 | -0.9% | 0.21% | +2.4% |
| Q4 2017 | $7,432,000 | -1.0% | 114,978 | -3.9% | 0.20% | -6.0% |
| Q3 2017 | $7,507,000 | +3.7% | 119,636 | +0.1% | 0.22% | -4.4% |
| Q2 2017 | $7,236,000 | +100.4% | 119,524 | +71.7% | 0.23% | +101.8% |
| Q1 2017 | $3,610,000 | +18.0% | 69,600 | +0.9% | 0.11% | +11.9% |
| Q4 2016 | $3,059,000 | +4.5% | 68,983 | +12.2% | 0.10% | +4.1% |
| Q3 2016 | $2,927,000 | +113.5% | 61,496 | +102.8% | 0.10% | +102.1% |
| Q2 2016 | $1,371,000 | +14.5% | 30,318 | +4.0% | 0.05% | +11.6% |
| Q1 2016 | $1,197,000 | +7.9% | 29,151 | +0.3% | 0.04% | +7.5% |
| Q4 2015 | $1,109,000 | +17.5% | 29,062 | +1.1% | 0.04% | +11.1% |
| Q3 2015 | $944,000 | -57.3% | 28,733 | -9.0% | 0.04% | -52.0% |
| Q2 2015 | $2,209,000 | -34.0% | 31,580 | -35.4% | 0.08% | -33.6% |
| Q1 2015 | $3,348,000 | -49.9% | 48,872 | -46.3% | 0.11% | -50.9% |
| Q4 2014 | $6,676,000 | +84.7% | 91,087 | +80.8% | 0.23% | +90.1% |
| Q3 2014 | $3,615,000 | +84.1% | 50,374 | +85.4% | 0.12% | +92.1% |
| Q2 2014 | $1,964,000 | -19.6% | 27,166 | -18.2% | 0.06% | -22.2% |
| Q1 2014 | $2,443,000 | +56.3% | 33,197 | +47.7% | 0.08% | +55.8% |
| Q4 2013 | $1,563,000 | -70.8% | 22,474 | -72.5% | 0.05% | -73.3% |
| Q3 2013 | $5,360,000 | -3.8% | 81,596 | +1.4% | 0.20% | -7.6% |
| Q2 2013 | $5,573,000 | – | 80,461 | – | 0.21% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SECTOR GAMMA AS | 713,500 | $49,895,000 | 12.74% |
| Veritas Asset Management LLP | 7,636,450 | $534,017,000 | 7.53% |
| FIRST NEW YORK SECURITIES LLC /NY | 154,158 | $10,780,269,000 | 5.40% |
| Gabalex Capital Management LLC | 200,000 | $14,981,000 | 5.39% |
| Veritas Investment Management LLP | 291,825 | $18,816,000 | 5.32% |
| Tweedy, Browne Co LLC | 2,543,966 | $177,900,000 | 4.91% |
| York Capital Management Global Advisors, LLC | 8,074,375 | $564,641,000 | 4.78% |
| First Fiduciary Investment Counsel, Inc. | 270,675 | $18,928,000 | 4.10% |
| SCHARF INVESTMENTS, LLC | 2,247,225 | $157,148,000 | 4.03% |
| Osher Van de Voorde Investment Management | 96,235 | $6,730,000 | 3.91% |